ESS2 and prostate cancer: To this end, we established ESS2-knockdown PC3 prostate cancer cells and found that these cells showed reduced proliferation accompanied by aberrant mRNA expression of nuclear factor (NF)-κB/CHD1 and prostate cancer-related genes.